Project Number AARG-22-927100 Agency/Funding Organization Alzheimer's Association Funding Year 2022 View Full Project Details for Cholinergic & noradrenergic contributions to presymptomatic AD progression Research Categorization Primary Disease / Condition Alzheimer's Disease CADRO Category A. Molecular Pathogenesis and Physiology of Alzheimer's Disease and Alzheimer's Disease-related Dementias (AD/ADRDs) 7. Circuits and Synapses c. Neurotransmitter Receptors Structure and Function Researcher and Organization Principal Investigator Spreng, R. Nathan Principal Investigator First Name R. Nathan Principal Investigator Last Name Spreng Awardee Organization The Royal Institution for the Advancement of Learning/McGill University Awardee State Québec Contact PI Country Canada Project Detail Funding Opportunity Announcement AARG FY Overall Cost $148,500 Funding Organization Agency/Funding Organization Alzheimer's Association Funding Organization Country United States Program Official Alzheimer's Association
